Evidence map›Paper›PMID 40713851›Full record

ArticleHuman genomics2025

A genome-wide pleiotropy study between atopic dermatitis and neuropsychiatric disorders.

Charalabos Antonatos, Alexandros Pontikas, Adam Akritidis, Dimitra Mitsoudi, Sophia Georgiou, Alexander J Stratigos, Aikaterini Zacharopoulou, Stamatis Gregoriou, Katerina Grafanaki, Yiannis Vasilopoulos

Abstract read
In one paragraph

Article in Human genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Single-CellInternational journal of molecular sciences · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Charalabos AntonatosLaboratory of Genetics, Section of Genetics, Cell Biology and Development, Department of Biology, University of Patras, 26504, Patras, Greece.
Alexandros PontikasLaboratory of Genetics, Section of Genetics, Cell Biology and Development, Department of Biology, University of Patras, 26504, Patras, Greece.
Adam AkritidisLaboratory of Genetics, Section of Genetics, Cell Biology and Development, Department of Biology, University of Patras, 26504, Patras, Greece.
Dimitra MitsoudiLaboratory of Genetics, Section of Genetics, Cell Biology and Development, Department of Biology, University of Patras, 26504, Patras, Greece.
Sophia GeorgiouDepartment of Dermatology-Venereology, School of Medicine, University of Patras, 26504, Patras, Greece.
Alexander J StratigosDepartment of Dermatology-Venereology, Faculty of Medicine, Andreas Sygros Hospital, National and Kapodistrian University of Athens, 16121, Athens, Greece.
Aikaterini ZacharopoulouDepartment of Dermatology-Venereology, Faculty of Medicine, Andreas Sygros Hospital, National and Kapodistrian University of Athens, 16121, Athens, Greece.
Stamatis GregoriouDepartment of Dermatology-Venereology, Faculty of Medicine, Andreas Sygros Hospital, National and Kapodistrian University of Athens, 16121, Athens, Greece.
Katerina GrafanakiDepartment of Dermatology-Venereology, School of Medicine, University of Patras, 26504, Patras, Greece.
Yiannis VasilopoulosLaboratory of Genetics, Section of Genetics, Cell Biology and Development, Department of Biology, University of Patras, 26504, Patras, Greece. iovasilop@upatras.gr.

Funding

National Eczema Association NEA23-CRG186
6 · The paper itself

Abstract

Atopic dermatitis (AD) frequently co-occurs with neuropsychiatric disorders, yet the genetic basis for this comorbidity is unclear. We performed a large-scale genome-wide pleiotropy approach to investigate the genetic correlations and causal associations between AD and five neuropsychiatric disorders, attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), bipolar disorder (BP), major depressive disorder (MDD), and schizophrenia (SCZ). We identified significant positive genetic correlations between AD and ADHD, MDD and BP. Genome-wide pleiotropy scans identified 37 distinct pleiotropic loci, mapped in 86 unique genes participating in inflammatory pathways. Pleiotropy-informed target prioritization facilitated the identification of novel pathophysiological mechanisms for AD and putative drug targets, such as members of TNF and JAK-STAT3 signaling. Mendelian randomization provided evidence of a causal relationship between genetic liability to MDD and BP in increased AD risk, independent of sample overlap. Our findings elucidate immune-related pathway crosstalks between AD and neuropsychiatric disorders with implications for therapeutic interventions.

Indexed as

Attention Deficit Disorder with HyperactivityBipolar DisorderDermatitis, AtopicGenetic PleiotropyMajor Depressive DisorderMental DisordersAutism Spectrum DisorderFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansMaleMendelian Randomization AnalysisPolymorphism, Single NucleotideSchizophrenia

Identifiers

PMID40713851
PMCPMC12297686

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.